MedPath

Compare the effect of Tetoltoredine and solifenacin in treatment of over active bladder symptoms.

Phase 2
Conditions
stress incontinance.
stress incontinance
Registration Number
IRCT2016101727998N3
Lead Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Inclusion Criteria: Age more than 18 years; Urge incontinence; Mixed incontinence; urination in the day more than 8 times and urination in the night more than once; more than once a day with urge incontinence; Sense of urgency to urinate in 24 hours.

Exclusion Criteria

Lack of consent to the participation; Contraindications received antimuscarinic drugs such as glaucoma.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary frequency. Timepoint: Before and two month after treatment. Method of measurement: Specific Questionaire.;Nuctury ( frequency of night urination ). Timepoint: Before and two month after treatment. Method of measurement: Specific Questionaire.
Secondary Outcome Measures
NameTimeMethod
Drug complication. Timepoint: two month after treatment. Method of measurement: Ask the patient.
© Copyright 2025. All Rights Reserved by MedPath